The US Food and Drug Administration (FDA) recently announced a recall of the highest severity level for a mobile application connected to an insulin pump. The application, the t:connect Mobile App iOS v2.7 from Tandem Diabetes Care, was recalled due to a bug that affected its communication with the t:slim X2 insulin pump.
This software error could put diabetes patients, who rely on the app to control their insulin levels, at serious health risk. The FDA has advised patients to stop using the affected version of the app for the time being, and go back to using the insulin pump's integrated user interface, until the problem is resolved. The company Tandem Diabetes Care is already fixing the problem and is expected to make a corrected software update available soon. In the meantime, users have been encouraged to keep a close eye on their glucose levels and consult their healthcare professionals about their insulin management.
In the analysis of the problem in question, it was observed that this application - intended to be synchronized with the t:slim X2 insulin pump - stops and restarts abruptly, which can lead to the pump's battery running out quickly and users being unable to access or control it via the application. In these situations, interruptions in insulin administration can occur, posing serious health problems for patients dependent on the pump.
The original article via BaselineMag can be read here.
